Discovery of new serum biomarker panels for systemic lupus erythematosus diagnosis
Rheumatology Jan 14, 2020
Ling HZ, Xu SZ, Leng RX, et al. - Researchers analyzed sera from 15 SLE people and five healthy volunteers by utilizing human proteome microarrays to recognize candidate SLE-related autoantibodies in order to systematically investigate new autoantibodies that might be good biomarkers for use in SLE diagnosis. A total of 31, 11 and 18 autoantibodies were recognized to be expressed at notably higher levels in the SLE group in comparison with the healthy volunteers, disease controls and healthy volunteers plus disease control groups, respectively, with 25, 7 and 13 of these variably expressed autoantibodies being priorly unreported. It was found that the combined autoantibody panels recognized here display promise for the diagnosis of SLE and for differential diagnosis of different major rheumatic immune diseases.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries